Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Abstract Text:

Alejandro Gugliucci,Nicole Lunceford,Eriko Kinugasa,Hiroaki Ogata,John Schulze,Satoshi Kimura,

BACKGROUND: Acrolein is a very reactive aldehyde present in cigarette smoke and endogenously generated by pathways such as lipid peroxidation and threonine metabolism by phagocytes. Acrolein has been shown to affect uptake of cholesterol by HDL. We hypothesized that acrolein could also have deleterious effects on paraoxonase 1 (PON-1) activity. We also determined whether free serum acrolein levels are higher in renal failure, and assessed whether they decrease after hemodialysis (HD) and whether this change correlates with increases in PON-1 activity. METHODS: We incubated human HDL with 0-10 mmol/l acrolein for 2 h and measured PON-1 activity and structural changes. Acrolein was also measured in 40 end stage renal disease (ESRD) patients (before and after a hemodialysis session), and 40 control subjects. RESULTS: We found that acrolein inhibits PON-1 activity in HDL in a time and concentration dependent fashion. Inhibition occurred at 40% at 0.5 mmol/l and was cancelled by cysteine but not by aminoguanidine or carnosine. We confirm that free serum acrolein levels are higher in chronic renal failure patients and demonstrate that they are partially removed by HD. Decrease in acrolein levels after dialysis correlate with increases in PON-1 activity (r=0.32, p 0.01). CONCLUSION: Acrolein inactivates paraoxonase 1 in HDL, a process that is inhibited by N-acetylcysteine. We confirm that acrolein levels are higher in ESRD and show for the first time, data supporting that acrolein is partially removed by hemodialysis. Decrease in acrolein levels after dialysis correlates with increase in PON-1 activity. This could offer new insights to explain low PON-1 activities in smokers and renal failure subjects as well as pointing at thiol-conserving reducing compounds such as N-acetylcysteine, as putative therapeutic palliatives.

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Publishing Authors By Initials

A Gugliucci,N Lunceford,E Kinugasa,H Ogata,J Schulze,S Kimura,

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Clinica chimica acta; international journal of cli

VOLUME: 384

Page Numbers: 105-12

Journal Abbreviation: Clin. Chim. Acta

ISSN: 0009-8981

DAY: 23

MONTH: 06

YEAR: 2007

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 1302422

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: metabolism

Chemical & Substance for Abstract: Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Information

Substance Name: Aryldialkylphosphatase

Registry Number: EC 3.1.8.1

Grant and Affiliation Information for Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.

AFFILIATION: Glycation, Oxidation and Disease Laboratory, Division of Basic Medical Sciences, Touro University-California, Mare Island, Vallejo, CA, USA. agugliuc@touro.edu

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Chim Acta

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients Related Publications

• A fermentation product of phytosterol including campestenone reduces body fat storage and body weight gain in mice.
• A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).
• A simple accurate method of alignment of beamline optics with the use of EUV multilayer polarizers.
• Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
• Enhanced stereocomplex formation of poly(L-lactic acid) and poly(D-lactic acid) in the presence of stereoblock poly(lactic acid).
• Enhancing effect of medium-chain triglycerides on intestinal absorption of d-alpha-tocopherol acetate from lecithin-dispersed preparations in the rat.
• Exposure of pregnant mice to an air pollutant aerosol increases asthma susceptibility in offspring.
• Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
• Fumiquinones A and B, nematicidal quinones produced by Aspergillus fumigatus.
• Further investigations of enhancing effect of medium-chain triglycerides on d-alpha-tocopherol acetate absorption from lecithin-dispersed preparations in rat small intestine.
• Generalized grazing-incidence-angle X-ray diffraction (G-GIXD) using image plates.
• Human opioid peptide Met-enkephalin binds to anionic phosphatidylserine in high preference to zwitterionic phosphatidylcholine: natural-abundance 13C NMR study on the binding state in large unilamellar vesicles.
• Identification of nucleotide residues essential for RNase P activity from the hyperthermophilic archaeon Pyrococcus horikoshii OT3.
• Idiopathic spinal cord herniation. Report of two cases and review of the literature.
• Induction of proinflammatory cytokines and caspase-1 by leptin in monocyte/macrophages from holstein cows.
• Inhibitory activity of linoleic acid isolated from proso and Japanese millet toward histone deacetylase.
• Interferon-gamma attenuates the survival activity of G-CSF through PI3K/Akt signaling pathway in mouse multipotent progenitor cells.
• Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to Ser.
• Mycotic aneurysm of the right coronary artery.
• Paradoxical brain embolism may not be uncommon-prospective study in acute ischemic stroke.
• Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan.
• Structural analysis of obscurin gene in hypertrophic cardiomyopathy.
• Synthesis and structure-activity relationship of RXR antagonists based on the diazepinylbenzoic acid structure.
• Synthesis and structure-activity relationship of novel RXR antagonists: orally active anti-diabetic and anti-obesity agents.
• [In Process Citation]
• [In Process Citation]
• [MicroRNAs: novel class of gene regulators involved in endocrine function and cancer]
• [Polymorphism on codon 98 of the galectin-3 gene are not associated to benign and malignant thyroid tumors]
• [Thermal expansion of layering porcelains for the tetragonal stabilized zirconia]
• [Tocopherol Acetate Reference Standard (Control 881) of National Institute of Hygienic Sciences]